RENAL-TRANSPLANTATION FOR PATIENTS WITH TYPE-I AND TYPE-II MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS - SERIAL COMPLEMENT AND NEPHRITIC FACTOR MEASUREMENTS AND THE PROBLEM OF RECURRENCE OF DISEASE

被引：40

作者：

CURTIS, JJ

WYATT, RJ

BHATHENA, D

LUCAS, BA

HOLLAND, NH

LUKE, RG

机构：

[1] UNIV KENTUCKY,MED CTR,DEPT MED,LEXINGTON,KY 40506

[2] UNIV KENTUCKY,MED CTR,DEPT PATHOL,LEXINGTON,KY 40506

[3] UNIV KENTUCKY,MED CTR,DEPT PEDIAT,LEXINGTON,KY 40506

[4] UNIV KENTUCKY,MED CTR,DEPT SURG,LEXINGTON,KY 40506

来源：

AMERICAN JOURNAL OF MEDICINE | 1979年 / 66卷 / 02期

关键词：

D O I：

10.1016/0002-9343(79)90530-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：216 / 225

页数：10

共 38 条

[21] DEFECT OF CEREBELLAR PURKINJE-CELL HISTOGENESIS ASSOCIATED WITH TYPE-I AND TYPE-II RENAL CYSTIC-DISEASE
KORNGUTH, S
KNOBELOCH, L
VISESKUL, C
GILBERT, E
OPITZ, J
ACTA NEUROPATHOLOGICA, 1977, 40 (01) : 1 - 9
[22] ANALYSIS OF THE SEROLOGICAL AND CELLULAR SENSITIZATION INDUCED BY ENCAPSULATED HUMAN ISLETS TRANSPLANTATION IN TYPE-I AND TYPE-II DIABETES PATIENTS
SHIROKI, R
MOHANAKUMAR, T
SCHARP, DW
CELL TRANSPLANTATION, 1995, 4 (05) : 535 - 538
[23] A NEW VARIANT OF VONWILLEBRAND DISEASE (TYPE-II TYPE-I) WITH A NORMAL DEGREE OF PROTEOLYTIC CLEAVAGE OF VONWILLEBRAND-FACTOR
CASTAMAN, G
RODEGHIERO, F
LATTUADA, A
MANNUCCI, PM
THROMBOSIS RESEARCH, 1992, 65 (03) : 343 - 351
[24] GLUCOCEREBROSIDASE PROCESSING IN NORMAL FIBROBLASTS AND IN FIBROBLASTS FROM PATIENTS WITH TYPE-I, TYPE-II, AND TYPE-III GAUCHER DISEASE
BEUTLER, E
KUHL, W
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (19) : 7472 - 7474
[25] Membranoproliferative Glomerulonephritis Type I in Renal Transplantation Patients: A Single-Center Study of a Cohort of 68 Renal Transplants Followed Up for 11 Years
Moroni, Gabriella
Casati, Costanza
Quaglini, Silvana
Gallelli, Beniamina
Banfi, Giovanni
Montagnino, Giuseppe
Messa, Piergiorgio
TRANSPLANTATION, 2011, 91 (11) : 1233 - 1239
[26] RACIAL-DIFFERENCES IN THE INCIDENCE OF END-STAGE RENAL-DISEASE IN TYPE-I AND TYPE-II DIABETES-MELLITUS
STEPHENS, GW
GILLASPY, JA
CLYNE, D
MEJIA, A
POLLAK, VE
AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 15 (06) : 562 - 567
[27] COMPLEMENT DEPOSITION IN THE GLOMERULAR-BASEMENT-MEMBRANE IS THE INITIAL PATHOLOGICAL EVENT IN PORCINE FACTOR-H DEFICIENCY LEADING TO LETHAL MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN) TYPE-II
JANSEN, JH
HOGASEN, K
GRONDAHL, AM
MOLLNES, TE
HARBOE, M
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1016 - 1016
[28] LEVELS OF SOLUBLE RECEPTORS FOR TUMOR-NECROSIS-FACTOR TYPE-I AND TYPE-II IN PAIRED SYNOVIAL-FLUIDS OF ARTHRITIS PATIENTS
MILTENBURG, AMM
ADERKA, D
VANLAAR, JM
WALLACH, D
BREEDVELD, FC
RHEUMATOLOGY INTERNATIONAL, 1993, 13 (03) : 117 - 119
[29] CORRELATION BETWEEN CIRCULATING LEVELS OF VONWILLEBRANDS ANTIGEN-II AND VONWILLEBRAND-FACTOR - DISCRIMINATION BETWEEN TYPE-I AND TYPE-II VONWILLEBRANDS DISEASE
MCCARROLL, DR
RUGGERI, ZM
MONTGOMERY, RR
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1984, 103 (05): : 704 - 711
[30] COMPARISON OF TYPE-II AND TYPE-I DIABETICS TREATED FOR END-STAGE RENAL-DISEASE IN A LARGE PREPAID HEALTH PLAN POPULATION
ORDONEZ, JD
HIATT, RA
NEPHRON, 1989, 51 (04): : 524 - 529

← 1 2 3 4 →